Horizon Kinetics Asset Management LLC Akebia Therapeutics, Inc. Call Options Transaction History

Horizon Kinetics Asset Management LLC

  • $6.03 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$3.16 - $6.73 $366,560 - $780,680
-116,000 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$3.55 - $5.4 $644,325 - $980,100
-181,500 Reduced 61.01%
116,000 $1.16 Million
Q2 2019

Aug 14, 2019
BUY
$4.1 - $8.05 $1.22 Million - $2.39 Million
297,500 New
297,500 $2.3 Million

Others Institutions Holding AKBA

# of Institutions
120
Shares Held
54.8M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $324M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Horizon Kinetics Asset Management LLC Portfolio

Follow Horizon Kinetics Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email